Business
BACTIQ: Q1 2026 revenue up 29% year-over-year, driven by recurring Pharma sales and new hospital hardware deal
BACTIQ: Q1 2026 revenue up 29% year-over-year, driven by recurring Pharma sales and new hospital hardware deal
About this update from Bactiquant A/s
Q1 2026 revenue rose 29% year-over-year to DKK 3.3 million, led by strong recurring revenue in Pharma and a major hardware sale to a hospital. Guidance for 2026 remains unchanged, with liquidity expected to last through 2027.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.